Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Design Therapeutics, Inc. (DSGN) had Weighted-Average Shares Outstanding (Diluted) of 56.95M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-17.00M |
|
-- |
|
-- |
|
$19.31M |
|
$-19.31M |
|
$2.31M |
|
$-17.00M |
|
$-17.00M |
|
$-17.00M |
|
$-17.00M |
|
$-17.00M |
|
$-17.00M |
|
$-19.31M |
|
$-19.92M |
|
56.95M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
56.95M |
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$209.03M |
|
$1.10M |
|
$2.74M |
|
$211.77M |
|
$11.17M |
|
-- |
|
$0.88M |
|
$12.05M |
|
$199.72M |
|
$199.72M |
|
$199.72M |
|
56.96M |
|
| Cash Flow Statement Financials | |
$-42.39M |
|
$34.50M |
|
$0.42M |
|
$22.56M |
|
$15.09M |
|
$-7.47M |
|
$11.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.51% |
|
-8.51% |
|
-8.03% |
|
-8.51% |
|
$3.51 |
|
$-0.75 |
|
$-0.74 |
|